These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 12910681

  • 21. [Experimental study on 5-fluourouracil-loaded immunonanoparticles targeting to lens epithelial cells].
    Li XR, Liu XL, Chang J, Liu XY.
    Zhonghua Yan Ke Za Zhi; 2006 Jun; 42(6):526-30. PubMed ID: 16857133
    [Abstract] [Full Text] [Related]

  • 22. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB, Yan ML, Gong JP, Xia RP, Liu LX, Li N, Lu SC, Zhang JG, Zeng DB, Xie JG, Yang JY, Yan LN.
    Chin Med J (Engl); 2007 Apr 20; 120(8):703-7. PubMed ID: 17517188
    [Abstract] [Full Text] [Related]

  • 23. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Sun LR, Li X, Cheng YN, Yuan HY, Chen MH, Tang W, Ward SG, Qu XJ.
    Biomed Pharmacother; 2009 Mar 20; 63(3):202-8. PubMed ID: 18818047
    [Abstract] [Full Text] [Related]

  • 24. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR, Gründker C, Bongertz T, Schlott T, Nagy A, Schally AV, Emons G.
    Am J Obstet Gynecol; 2004 Oct 20; 191(4):1164-72. PubMed ID: 15507937
    [Abstract] [Full Text] [Related]

  • 25. Reversal effects of hyaluronan oligosaccharides on adriamycin resistance of K562/A02 cells.
    Cui X, Zhou S, Xu H, Zhao T, Liu A, Guo X, Wang F.
    Anticancer Drugs; 2009 Oct 20; 20(9):800-6. PubMed ID: 19606017
    [Abstract] [Full Text] [Related]

  • 26. [MDR-reversing effect of short peptide binding specifically to multidrug-resistant gastric cancer cells].
    Wang P, Ding J, Lin T, Han S, Cao SS, Ge FL, An GQ, Li R, Lei T, Bai FH, Fan DM.
    Zhonghua Zhong Liu Za Zhi; 2007 Apr 20; 29(4):258-61. PubMed ID: 17760250
    [Abstract] [Full Text] [Related]

  • 27. Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms.
    Serafino A, Sinibaldi-Vallebona P, Gaudiano G, Koch TH, Rasi G, Garaci E, Ravagnan G.
    Anticancer Res; 1998 Apr 20; 18(2A):1159-66. PubMed ID: 9615782
    [Abstract] [Full Text] [Related]

  • 28. [MDR-reversing effect of two components of catechin on human hepatocellular carcinoma BEL-7404/Adr in vitro].
    Liang G, Zhang S, Huang ZM, Tang AZ.
    Ai Zheng; 2004 Apr 20; 23(4):401-5. PubMed ID: 15087027
    [Abstract] [Full Text] [Related]

  • 29. Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model.
    Ding L, Chen XP, Zhang ZW, Jing K, Zhang WG.
    Hepatobiliary Pancreat Dis Int; 2007 Aug 20; 6(4):393-8. PubMed ID: 17690036
    [Abstract] [Full Text] [Related]

  • 30. Optimization of ultrasound-mediated in vitro reversal of multidrug resistance in human hepatocarcinoma cell line HepG2.
    Zhai BJ, Shao ZY, Zhao CL, Hu K, Shen DM, Wu F.
    Ultrasound Med Biol; 2008 Oct 20; 34(10):1697-702. PubMed ID: 18468774
    [Abstract] [Full Text] [Related]

  • 31. Genetic alterations in doxorubicin-resistant hepatocellular carcinoma cells: a combined study of spectral karyotyping, positional expression profiling and candidate genes.
    Hu Y, Pang E, Lai PB, Squire JA, MacGregor PF, Beheshti B, Albert M, Leung TW, Wong N.
    Int J Oncol; 2004 Nov 20; 25(5):1357-64. PubMed ID: 15492826
    [Abstract] [Full Text] [Related]

  • 32. Reversal effect of Ganoderma lucidum polysaccharide on multidrug resistance in K562/ADM cell line.
    Li WD, Zhang BD, Wei R, Liu JH, Lin ZB.
    Acta Pharmacol Sin; 2008 May 20; 29(5):620-7. PubMed ID: 18430371
    [Abstract] [Full Text] [Related]

  • 33. Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.
    Yang JY, Luo HY, Lin QY, Liu ZM, Yan LN, Lin P, Zhang J, Lei S.
    World J Gastroenterol; 2002 Aug 20; 8(4):644-9. PubMed ID: 12174371
    [Abstract] [Full Text] [Related]

  • 34. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
    Krishna CM, Kegelaer G, Adt I, Rubin S, Kartha VB, Manfait M, Sockalingum GD.
    Biopolymers; 2006 Aug 05; 82(5):462-70. PubMed ID: 16493658
    [Abstract] [Full Text] [Related]

  • 35. Induction of apoptosis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering?
    Serafino A, Sinibaldi-Vallebona P, Pierimarchi P, Bernard P, Gaudiano G, Massa C, Rasi G, Ranagnan G.
    Anticancer Res; 1999 Aug 05; 19(3A):1909-18. PubMed ID: 10470135
    [Abstract] [Full Text] [Related]

  • 36. Induction of apoptosis by AN-152, a cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), in LHRH-R positive human breast cancer cells is independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR, Gründker C, Bongertz T, Nagy A, Schally AV, Emons G.
    Breast Cancer Res Treat; 2004 Oct 05; 87(3):255-64. PubMed ID: 15528968
    [Abstract] [Full Text] [Related]

  • 37. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 38. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS, Hua J, Gibb RK, Mutch DG, Herzog TJ.
    Gynecol Oncol; 2004 Jul 21; 94(1):67-73. PubMed ID: 15262121
    [Abstract] [Full Text] [Related]

  • 39. In vitro cytotoxic study of immunoliposomal doxorubicin targeted to human CD34(+) leukemic cells.
    Carrion C, de Madariaga MA, Domingo JC.
    Life Sci; 2004 Jun 04; 75(3):313-28. PubMed ID: 15135652
    [Abstract] [Full Text] [Related]

  • 40. Gene expressions associated with chemosensitivity in human hepatoma cells.
    Hoshida Y, Moriyama M, Otsuka M, Kato N, Taniguchi H, Shiratori Y, Seki N, Omata M.
    Hepatogastroenterology; 2007 Mar 04; 54(74):489-92. PubMed ID: 17523305
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.